Fibroblasts in pancreatic cancer: molecular and clinical perspectives

Ho, 2020, The tumour microenvironment in pancreatic cancer – clinical challenges and opportunities, Nat. Rev. Clin. Oncol., 17, 527, 10.1038/s41571-020-0363-5 Kalluri, 2016, The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, 16, 582, 10.1038/nrc.2016.73 Bachem, 1998, Identification, culture, and characterization of pancreatic stellate cells in rats and humans, Gastroenterology, 115, 421, 10.1016/S0016-5085(98)70209-4 Apte, 1998, Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture, Gut, 43, 128, 10.1136/gut.43.1.128 Erkan, 2012, StellaTUM: current consensus and discussion on pancreatic stellate cell research, Gut, 61, 172, 10.1136/gutjnl-2011-301220 Biffi, 2021, Diversity and biology of cancer-associated fibroblasts, Physiol. Rev., 101, 147, 10.1152/physrev.00048.2019 Tian, 2016, Activation of pancreatic stellate cells involves an EMT-like process, Int. J. Oncol., 48, 783, 10.3892/ijo.2015.3282 Ozdemir, 2014, Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival, Cancer Cell, 25, 719, 10.1016/j.ccr.2014.04.005 Ramanathan, 2019, Phase IB/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313, J. Clin. Oncol., 37, 1062, 10.1200/JCO.18.01295 Djurec, 2018, Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors, Proc. Natl. Acad. Sci. U. S. A., 115, E1147, 10.1073/pnas.1717802115 Elyada, 2019, Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts, Cancer Discov., 9, 1102, 10.1158/2159-8290.CD-19-0094 Ohlund, 2017, Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer, J. Exp. Med., 214, 579, 10.1084/jem.20162024 Biffi, 2019, IL1-induced JAK/STAT signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma, Cancer Discov., 9, 282, 10.1158/2159-8290.CD-18-0710 Huang, 2021, Extracellular matrix and its therapeutic potential for cancer treatment, Signal. Transduct. Target Ther., 6, 153, 10.1038/s41392-021-00544-0 Nallanthighal, 2019, The role of the extracellular matrix in cancer stemness, Front Cell Dev. Biol., 7, 86, 10.3389/fcell.2019.00086 Hwang, 2019, Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells, J. Exp. Clin. Cancer Res., 38, 258, 10.1186/s13046-019-1225-9 Amrutkar, 2019, Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells, BMC Cancer, 19, 596, 10.1186/s12885-019-5803-1 Wang, 2017, Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms, Cancer Lett., 398, 24, 10.1016/j.canlet.2017.04.001 Liu, 2016, Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer, Tumour. Biol., 37, 15283, 10.1007/s13277-016-5321-6 Elahi-Gedwillo, 2019, Antifibrotic therapy disrupts stromal barriers and modulates the immune landscape in pancreatic ductal adenocarcinoma, Cancer Res., 79, 372, 10.1158/0008-5472.CAN-18-1334 Glaser, 2012, Review of MR elastography applications and recent developments, J. Magn. Reson. Imaging, 36, 757, 10.1002/jmri.23597 Maloney, 2019, Non-invasive monitoring of stromal biophysics with targeted depletion of hyaluronan in pancreatic ductal adenocarcinoma, Cancers (Basel), 11, 10.3390/cancers11060772 Ligorio, 2019, Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer, Cell, 178, 160, 10.1016/j.cell.2019.05.012 Principe, 2016, TGFbeta signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis, Cancer Res., 76, 2525, 10.1158/0008-5472.CAN-15-1293 Al-Assar, 2014, Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells, Radiother. Oncol., 111, 243, 10.1016/j.radonc.2014.03.014 Zhang, 2018, Tumor–stroma IL1beta–IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer, Cancer Res., 78, 1700, 10.1158/0008-5472.CAN-17-1366 Guan, 2014, Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells, Cancer Lett., 345, 132, 10.1016/j.canlet.2013.12.006 Zhang, 2017, Constitutive IRAK4 activation underlies poor prognosis and chemoresistance in pancreatic ductal adenocarcinoma, Clin. Cancer Res., 23, 1748, 10.1158/1078-0432.CCR-16-1121 Hu, 2022, circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis, Mol. Cancer, 21, 24, 10.1186/s12943-022-01501-3 Shi, 2019, Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring, Nature, 569, 131, 10.1038/s41586-019-1130-6 Feig, 2013, Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer, Proc. Natl. Acad. Sci. U. S. A., 110, 20212, 10.1073/pnas.1320318110 Lee, 2021, Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis, Nat. Commun., 12, 7336, 10.1038/s41467-021-27607-8 Liu, 2022, Metastatic transition of pancreatic ductal cell adenocarcinoma is accompanied by the emergence of pro-invasive cancer-associated fibroblasts, Cancers (Basel), 14, 2197, 10.3390/cancers14092197 Théry, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750 Lopes-Rodrigues, 2017, Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles, Sci. Rep., 7, 44541, 10.1038/srep44541 Yanez-Mo, 2015, Biological properties of extracellular vesicles and their physiological functions, J. Extracell. Vesicles, 4, 27066, 10.3402/jev.v4.27066 Zhang, 2018, Micro-RNA-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer, Oncol. Res., 26, 827, 10.3727/096504017X14934840662335 Kuninty, 2016, MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor, Oncotarget, 7, 16396, 10.18632/oncotarget.7651 Li, 2020, Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway, Cancer Lett., 490, 20, 10.1016/j.canlet.2020.06.009 Ma, 2020, Upregulation of exosomal microRNA21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity, Int. J. Oncol., 56, 1025 Fang, 2019, Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer, Exp. Cell Res., 383, 10.1016/j.yexcr.2019.111543 Han, 2022, Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5–FAK axis, Cancer Biol. Ther., 23, 378, 10.1080/15384047.2022.2041961 Cao, 2021, Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway, Aging (Albany NY), 13, 7120, 10.18632/aging.202569 Chi, 2021, Exosomal lncRNA UCA1 derived from pancreatic stellate cells promotes gemcitabine resistance in pancreatic cancer via the SOCS3/EZH2 axis, Front Oncol., 11, 10.3389/fonc.2021.671082 Cheng, 2014, Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood, J. Extracell. Vesicles, 3, 23743, 10.3402/jev.v3.23743 Koga, 2011, Exosome can prevent RNase from degrading microRNA in feces, J. Gastrointest. Oncol., 2, 215 Spivak-Kroizman, 2013, Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer, Cancer Res., 73, 3235, 10.1158/0008-5472.CAN-11-1433 Richards, 2017, Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells, Oncogene, 36, 1770, 10.1038/onc.2016.353 Leca, 2016, Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness, J. Clin. Invest., 126, 4140, 10.1172/JCI87734 Zhao, 2016, Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism, Elife, 5, 10.7554/eLife.10250 Niederhuber, 2019 Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362 Xavier, 2021, Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine, Cancer Lett., 501, 210, 10.1016/j.canlet.2020.11.013 Nielsen, 2016, Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis, Nat. Cell Biol., 18, 549, 10.1038/ncb3340 Matsuo, 2009, CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer, Int. J. Cancer, 124, 853, 10.1002/ijc.24040 Gao, 2010, Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 axis, Pancreatology, 10, 186, 10.1159/000236012 Murphy, 2019, Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a Phase 2 clinical trial, JAMA Oncol., 5, 1020, 10.1001/jamaoncol.2019.0892 Hingorani, 2018, HALO 202: randomized Phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine versus nab-paclitaxel/gemcitabine in patients with untreated, metastatic pancreatic ductal adenocarcinoma, J. Clin. Oncol., 36, 359, 10.1200/JCO.2017.74.9564 Hakim, 2019, Why HALO 301 failed and implications for treatment of pancreatic cancer, Pancreas (Fairfax), 3, e1, 10.17140/POJ-3-e010 Borazanci, 2022, Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors, ESMO Open, 7, 10.1016/j.esmoop.2022.100530 O'Kane, 2022, Abstract CT126: a phase 2 trial of first-line AZD0171 + durvalumab and chemotherapy (CT) in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and CD8+ T cell infiltration, Cancer Res., 82, 10.1158/1538-7445.AM2022-CT126 Melisi, 2019, TGFbeta receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer, Cancer Chemother. Pharmacol., 83, 975, 10.1007/s00280-019-03807-4 Pijnappel, 2021, Phase I/II study of LDE225 in combination with gemcitabine and Nab-paclitaxel in patients with metastatic pancreatic cancer, Cancers (Basel), 13, 4869, 10.3390/cancers13194869 Steele, 2021, Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer, Clin. Cancer Res., 27, 2023, 10.1158/1078-0432.CCR-20-3715 Rhim, 2014, Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma, Cancer Cell, 25, 735, 10.1016/j.ccr.2014.04.021 Lo, 2015, Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells, Cancer Res., 75, 2800, 10.1158/0008-5472.CAN-14-3041 Mizutani, 2019, Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis, Cancer Res., 79, 5367, 10.1158/0008-5472.CAN-19-0454 Sherman, 2014, Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy, Cell, 159, 80, 10.1016/j.cell.2014.08.007 Grierson, 2022, A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer which progressed on gemcitabine-based therapy, J. Clin. Oncol., 40, 566, 10.1200/JCO.2022.40.4_suppl.566 Kocher, 2020, Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer, Nat. Commun., 11, 4841, 10.1038/s41467-020-18636-w Mizutani, 2022, Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma, BMC Cancer, 22, 205, 10.1186/s12885-022-09272-2 Iida, 2022, Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics, Oncogene, 41, 2764, 10.1038/s41388-022-02288-9 Wang, 2021, Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa, J. Transl. Med., 19, 39, 10.1186/s12967-021-02701-z Nissen, 2022, Collagen biomarkers quantify fibroblast activity in vitro and predict survival in patients with pancreatic ductal adenocarcinoma, Cancers (Basel), 14, 819, 10.3390/cancers14030819 Dings, 2023, Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer, Int. J. Cancer, 152, 511, 10.1002/ijc.34276 Miyazaki, 2022, Potential metabolite markers for pancreatic cancer identified by metabolomic analysis of induced cancer-associated fibroblasts, Cancers (Basel), 14, 1375, 10.3390/cancers14061375 Neuzillet, 2019, Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma, J. Pathol., 248, 51, 10.1002/path.5224 International Society for Extracellular Vesicles. https://www.isev.org/ Barbosa, 2021, 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs, Cancers (Basel), 14, 190, 10.3390/cancers14010190 Pandol, 2009, Desmoplasia of pancreatic ductal adenocarcinoma, Clin. Gastroenterol. Hepatol., 7, S44, 10.1016/j.cgh.2009.07.039 Neesse, 2011, Stromal biology and therapy in pancreatic cancer, Gut, 60, 861, 10.1136/gut.2010.226092 Provenzano, 2012, Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma, Cancer Cell, 21, 418, 10.1016/j.ccr.2012.01.007 Erkan, 2013, The role of pancreatic stellate cells in pancreatic cancer, Pancreatology, 13, 106, 10.1016/j.pan.2013.01.008 Erkan, 2007, Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity, Gastroenterology, 132, 1447, 10.1053/j.gastro.2007.01.031 Erkan, 2012, The role of stroma in pancreatic cancer: diagnostic and therapeutic implications, Nat. Rev. Gastroenterol. Hepatol., 9, 454, 10.1038/nrgastro.2012.115 Aichler, 2012, Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues, J. Pathol., 226, 723, 10.1002/path.3017 Xing, 2010, Cancer associated fibroblasts (CAFs) in tumor microenvironment, Front Biosci. (Landmark Ed), 15, 166, 10.2741/3613 Li, 2007, Tumor microenvironment: the role of the tumor stroma in cancer, J. Cell. Biochem., 101, 805, 10.1002/jcb.21159 Sahai, 2020, A framework for advancing our understanding of cancer-associated fibroblasts, Nat. Rev. Cancer, 20, 174, 10.1038/s41568-019-0238-1 Dvorak, 2015, Tumors: wounds that do not heal – redux, Cancer Immunol. Res., 3, 1, 10.1158/2326-6066.CIR-14-0209 Vonlaufen, 2008, Pancreatic stellate cells: partners in crime with pancreatic cancer cells, Cancer Res., 68, 2085, 10.1158/0008-5472.CAN-07-2477 Fukino, 2004, Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets, Cancer Res., 64, 7231, 10.1158/0008-5472.CAN-04-2866 Quante, 2011, Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth, Cancer Cell, 19, 257, 10.1016/j.ccr.2011.01.020 Waghray, 2016, GM-CSF mediates mesenchymal–epithelial cross-talk in pancreatic cancer, Cancer Discov., 6, 886, 10.1158/2159-8290.CD-15-0947 Zeisberg, 2007, Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts, Cancer Res., 67, 10123, 10.1158/0008-5472.CAN-07-3127 Han, 2020, Biomarkers for cancer-associated fibroblasts, Biomark Res., 8, 64, 10.1186/s40364-020-00245-w Geng, 2021, Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer, Front Cell Dev. Biol., 9, 10.3389/fcell.2021.655152 Bernard, 2019, Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression, Clin. Cancer Res., 25, 2194, 10.1158/1078-0432.CCR-18-1955 Hosein, 2019, Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution, JCI Insight, 5 Dominguez, 2020, Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy, Cancer Discov., 10, 232, 10.1158/2159-8290.CD-19-0644 Boyd, 2022, Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment, Semin. Cancer Biol., 82, 184, 10.1016/j.semcancer.2021.03.006 Zhan, 2017, Crosstalk between stromal cells and cancer cells in pancreatic cancer: new insights into stromal biology, Cancer Lett., 392, 83, 10.1016/j.canlet.2017.01.041 Froeling, 2011, Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt–beta-catenin signaling to slow tumor progression, Gastroenterology, 141, 1486, 10.1053/j.gastro.2011.06.047 Sarper, 2016, ATRA modulates mechanical activation of TGF-beta by pancreatic stellate cells, Sci. Rep., 6, 27639, 10.1038/srep27639 Allam, 2017, Pancreatic stellate cells in pancreatic cancer: In focus, Pancreatology, 17, 514, 10.1016/j.pan.2017.05.390 Roy, 2017, Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma, Lab. Investig., 97, 302, 10.1038/labinvest.2016.146 Fu, 2018, The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma, Mol. Cancer, 17, 62, 10.1186/s12943-018-0815-z Hanahan, 2022, Hallmarks of cancer: new dimensions, Cancer Discov., 12, 31, 10.1158/2159-8290.CD-21-1059 Faget, 2019, Unmasking senescence: context-dependent effects of SASP in cancer, Nat. Rev. Cancer, 19, 439, 10.1038/s41568-019-0156-2 Takikawa, 2022, Senescent human pancreatic stellate cells secrete CXCR2 agonist CXCLs to promote proliferation and migration of human pancreatic cancer AsPC-1 and MIAPaCa-2 cell lines, Int. J. Mol. Sci., 23, 9275, 10.3390/ijms23169275 Peng, 2013, Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer, PLoS One, 8 Wang, 2017, Senescent carcinoma-associated fibroblasts upregulate IL8 to enhance prometastatic phenotypes, Mol. Cancer Res., 15, 3, 10.1158/1541-7786.MCR-16-0192 Yamao, 2019, Cellular senescence, represented by expression of caveolin-1, in cancer-associated fibroblasts promotes tumor invasion in pancreatic cancer, Ann. Surg. Oncol., 26, 1552, 10.1245/s10434-019-07266-2